Fang CP, Yan HL, Gu ML, Jia Y, He CW, Tian ZF, Fu YY, Deng AM. Circulating tumor cells and cell tumor DNA methylation in gastric cancer: From bench to bedside.
Shijie Huaren Xiaohua Zazhi 2015;
23:44-50. [DOI:
10.11569/wcjd.v23.i1.44]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Gastric cancer is still one of malignant tumors with the highest morbidity and mortalit in China, and the 5-year survival rate is only 10%. Circulating tumor cells (CTCs) and cell tumor DNA (ctDNA) have gained increasing interests during the past decade. A wealth of information indicating the potential value of CTCs and ctDNA for cancer diagnosis, monitoring of the efficacy of anticancer therapies and prognosis has emerged. In this review, we discuss the biology and potential clinical use of CTCs and ctDNA in gastric cancer, as well as their role in the management of cancer patients.
Collapse